BVS

BVS Operating Expenses

$333.81MTTM · USD

Period ending:

BVS FY Operating ExpensesUSD
BVS FY Operating Expenses2013-12-31: $169.07M2014-12-31: $165.49M2015-12-31: $173.76M2016-12-31: $168.22M2017-12-31: $172.94M2018-12-31: $209.51M2019-12-06: $218.01M2020-12-31: $212.28M2021-12-31: $290.65M2022-12-31: $498.31M2023-12-31: $409.92M2024-12-31: $400.21M2025-12-31: $323.88M$498.31M$0.00
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BVS operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Bioventus Class A Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
323,883,000
400,205,000
409,918,000
498,314,000
290,645,000
212,282,000
218,013,000
209,505,000
172,938,000
168,221,000
173,758,000
165,491,000
169,071,000

Compare operating expenses

All BVS financial metrics · BVS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.